Culture filtrates of Shigellaflexneri 2a strain M4243 grown in iron-depleted medium, caused significant fluid accumulation in rabbit ileal loops. Also, when tested in Ussing chambers, a greater rise in potential difference and short circuit current was seen with such filtrates compared with the medium control. Analogous filtrates from two M4243 derivatives lacking the 140-MD invasiveness plasmid (either M4243avir or BS103) retained 60-65% of the wild-type enterotoxic activity. Ultrafiltration and gel exclusion size fractionation of M4243 filtrate revealed that the activity was 60 kD. SDS-PAGE performed on this fraction showed 18 bands, 5 of which reacted with human convalescent sera. Genes encoding this enterotoxin, named ShET1 for Shigella enterotoxin 1, were cloned from the S. flexneri 2a chromosome, and two separate open reading frames of 534 and 186 bp were sequenced. These observations suggest that S. flexneri 2a elaborates two distinct enterotoxins: ShET1, encoded by genes located on the chromosome, and ShET2, encoded by a gene on the 140-MD invasiveness plasmid. ShET1, which is composed of two distinct subunits and is elaborated in vivo, where it elicits an immune response, may be important in the pathogenesis of diarrheal illness due to S. flexneri 2a. (J. Clin. Invest. 1995Invest. . 95:2853Invest. -2861
Introduction
Although the cardinal feature in the pathogenesis of Shigella flexneri infection involves the invasion of epithelial cells, it nevertheless has been hypothesized that S. flexneri also produces an enterotoxin ( 1, 2) . Support for this hypothesis was obtained by Rout et al. (1) , who documented jejunal secretion in experimental shigellosis in monkeys challenged with the prototype wild-type S. flexneri 2a strain M4243. We have previously re-68-80 kD) that causes fluid accumulation in isolated rabbit ileal loops and an electrical response in Ussing chambers (3) . Based on the similarities known to exist between EIEC and Shigella (4), we investigated the possibility that S. flexneri 2a expresses an enterotoxin ( s). Our group has recently cloned and sequenced the EIET gene (5) . We then found virtually the identical gene (99% homology) on the 140-MD invasiveness plasmid of S. flexneri 2a (5) , which we refer to as Shigella enterotoxin 2 (ShET2). In this report, we describe a second enterotoxin elaborated by S. flexneri 2a, its neutralization by homologous antitoxin, the distinction between the observed enterotoxicity and cytotoxicity, and the cloning and DNA sequencing of the chromosomal genes encoding the toxin.
Methods

Bacterial strains
The strains used in the present paper are listed in Table I . S. flexneri 2a strain M4243 was used for our animal studies, since Rout et al. (1) showed that, when fed to monkeys, this strain induced secretory diarrhea. M4243 and its plasmid-cured derivative M4243avir were obtained from the Walter Reed Army Institute of Research, Washington, D.C. M4243avir is a spontaneous plasmid-cured derivative of M4243 obtained after several passages of the wild-type strain at room temperature. To rule out the possibility that spontaneous mutations may have occurred in the genomic chromosome of M4243 that could account for the decreased enterotoxic activity of M4243avir, a second plasmid-cured de- rivative, BS103 (6) , was tested. BS103, kindly provided by Dr. Anthony Maurelli of the Uniformed Services University of the Health Sciences, Bethesda, MD, was obtained from the wild-type strain after a limited number of passages. S. flexneri 2a strain 2457T, which has been routinely used in volunteer challenge studies since the late 1960s (7) , was cured of the 140-MD invasiveness plasmid (2457TA) and used to clone the gene encoding the enterotoxic moiety. It should be noted that strain M4243 represents a clone isolated from the diarrheal stools of a monkey fed 2457T and that it is indistinguishable from 2457T. S. flexneri 2a strains 2457T and its plasmid-cured derivative 2457TA (low passage) came from the Center for Vaccine Development strain collection. Enterohemorrhagic E. coli (EHEC) strain 933 (serotype 0157:H7), which elaborates Shiga-like toxin I and II, was used as the positive control in the Vero cell cytotoxicity assay (3) . Nonpathogenic E. coli strain HS has been used extensively as a negative control in assays of pathogenicity and in clinical studies (8, 9) . The bacterial isolates were initially cultured on blood agar to assess their purity. Isolated colonies were Richmond, CA), iron-depleted syncase broth (10) in iron-free culture vessels. Supernatants were collected by centrifugation at 12,000 g for 20 min at 40C and passed through a 0.22-aum membrane filter.
Culture filtrates of M4243avir were size fractionated using a series of Diaflo ultrafilters (Amicon Corp., Danvers, MA) to approximate the molecular weight (MW) of the material eliciting enterotoxic activity in rabbit ileal loops and in Ussing chambers. YM100 (100,000 MW cutoff), YM30 (30,000 MW cutoff), and YCO5 (500 MW cutoff) membranes were used sequentially to fractionate the culture supernatants. Each membrane retentate was washed free of lower molecular weight species and exchanged into PBS, pH 7.3, on each membrane by two successive 1:10 dilutions with PBS, followed by concentration and final reconstitution to the original supernatant volume in PBS. Resulting supernatant fractions representing coarse pools of > 100, 30-100, and 0.5-30 kD were assayed for activity in rabbit ileal loops, Ussing chambers, and Vero cells.
Partial purification of enterotoxin
The M4243avir material exhibiting enterotoxic activity (30-100 kD) was further fractionated by size exclusion chromatography using a column with a fractionation range of 10-80 kD (Protein Pak 125; 7.8 x 300 mm with guard column; Millipore Corp., Waters Chromatography, Bedford, MA). The 30-100-kD fraction was prepared as previously described and further concentrated 100-fold on a YM30 membrane, and 200 p1 was applied to and eluted from the column with PBS at 0.5 ml/min. The eluate absorbance at 280 nm was monitored, 0.5-ml fractions were collected, and those exhibiting absorbance were assayed for activity in rabbit ileal loops and Ussing chambers.
Preparation of antitoxin in rabbits
New Zealand White male rabbits were used to produce antibodies for neutralization experiments. After obtaining a preimmunization serum specimen, 1 ml of the concentrated 30-100-kD enterotoxic fraction of M4243avir supernatants previously described was mixed with an equal volume of Freund's complete adjuvant and inoculated subcutaneously in four separate sites. A booster dose of pooled chromatographic fractions of 60 kD exhibiting activity was administered with Freund's incomplete adjuvant 4 wk later; 1 mo thereafter, the rabbit was bled.
For those experiments designed to identify ShETl as expressed in an E. coli host, this antiserum was absorbed for 20 min, three times, either with freshly harvested Epicurian coli strain XLl-Blue MRF' (pBluescript SK±) (Stratagene, La Jolla, CA) or with E. coli K12 strain DH5a (pBluescript SK±) before its use in immunoblots.
Human antitoxin
Pre-and postchallenge pooled sera from 10 adult volunteers who developed diarrhea after ingesting S. flexneri 2a M4243 while serving as unimmunized controls in vaccine efficacy studies ( 11) were prepared for use in neutralization experiments in Ussing chambers and in immunoblotting procedures.
Rabbit ileal loop test
Adult New Zealand White rabbits were used to perform the experiments as previously described (3) . Whole cultures of S. flexneri strain M4243 and its plasmid-cured derivative M4243avir, along with their respective sterile supernatants, were tested. Supernatant from nonpathogenic E. coli strain HS was also included in each experiment as a negative control (3) . At the end of the experiments, sections of intestine from each loop were fixed in 10% formalinized saline to be examined by light microscopy.
Ussing chambers
The experiments were performed by methods previously described in extensive details (12 
Results
Rabbit ileal loop test
The intestinal loops injected with whole viable cultures of M4243 showed pronounced fluid accumulation at 18 h after inoculation (Table II) . On histologic examination, severe tissue damage was observed, characterized by prominent necrosis of the luminal epithelium and marked villus atrophy (Fig. 1 a) .
It is notable that although M4243 sterile culture supernatant also induced a significant fluid accumulation as compared with the HS negative control (Table II) , no tissue damage was detected ( Fig. 1 b) . Fluid accumulation induced by M4243avir (both whole culture and sterile supernatant) was lower than M4243 supernatant-induced secretion, but still significantly higher than the negative control strain HS (Table II) ; no tissue damage was observed in the positive loops (data not shown).
The results of experiments clearly show that iron-limited culture conditions are required in order to detect expression of M4243 enterotoxic activity in sterile supernatants (Table Ill) . Expression was not notably affected by the length of incubation (Table III) .
Ussing chambers
The results obtained in the rabbit ileal loop assays were compatible with elaboration of an enterotoxin by M4243. To test this hypothesis, sterile crude supernatants obtained from iron-limited M4243, M4243avir, and BS103 cultures were tested in rabbit small intestine mounted in Ussing chambers. A 30-100-kD supernatant fraction from EIEC CVD/EI-34 (0136:H-) and HS supernatant were used as positive and negative controls, respectively. As shown in Table II , the overall increase in IS4
was significantly greater for M4243 supernatant as compared with the HS supernatant negative control. Repeated assays showed that supernatants from both of the plasmid-minus
Enterotoxins Elaborated by Shigella flexneri 2a 2855 strains, M4243avir and BS103, expressed significantly less enterotoxin in comparison with the plasmid-containing M4243 (Table II ; P < 0.05). However, the enterotoxic activity of the M4243avir and BS103 supernatants was nevertheless significantly greater than the negative control (Table II) . These data suggest that, though not absolutely necessary for the effect, the virulence plasmid of S. flexneri confers enhanced enterotoxic (Fig. 2 a) or with convalescent sera from volunteers who had been challenged with S. flexneri 2a (Fig. 2 b) . 
Preliminary estimate of enterotoxin size
To obtain a preliminary estimate of the molecular mass of the enterotoxin and to establish the correlation of enterotoxic and cytotoxic activities, supernatants from M4243avir grown in iron-limited medium were fractionated by membrane ultrafiltration. Three coarse size fractions were tested for enterotoxic activity in Ussing chambers and ileal loops and for cytotoxicity in Vero cells. As shown in Fig. 3 , both ileal loop (Fig. 3 a) and Ussing chamber (Fig. 3 b) assays localized the active enterotoxic fraction within the 30-100-kD size range. In contrast, the cytotoxic activity was detected exclusively in the < 30-kD fraction (data not shown).
Partial purification of the enterotoxin
The 30-100-kD fraction exhibiting enterotoxic activity was further fractionated by size using HPLC. Material eluting at times equivalent to -60 kD relative to molecular mass calibration standards was active in both ileal loops and Ussing chambers (Fig. 4) . This subfraction contained the bulk of the activity Enterotoxins Elaborated by Shigella flexneri 2a 2857 Further purification of enterotoxin Material from the large scale preparation representing a 100-fold concentrate of 30-100-kD supernatant from a 30-liter irondepleted culture of plasmid-cured S. flexneri 2a exhibited enterotoxic activity similar to levels observed for smaller batches. Pooled size exclusion fractions of 60 kD were shown to generate 18 bands when subjected to preparative SDS-PAGE, transferred to nitrocellulose, and stained with colloidal gold (Fig. 5, lane b) . A Western blot of the same material demonstrated that five of these bands reacted with convalescent sera from volunteers who had developed S. flexneri 2a diarrhea (Fig.  5, lane c (Fig. 6 B, lane b) . Fewer bands were recognized in the immunoblot using the human sera.
Sequencing of set. Sequencing analysis of the 6-kb insert in pF9-1-90 revealed two orfs of 186 bp (setlB) and 534 bp (setlA) in the same orientation and separated by only 6 bp (Fig.  7) . The predicted molecular masses of the protein molecules encoded by these orfs are 7 and 20 kD for setlB and setlA, respectively. The finding of a 55-kD protein (Fig. 6 A) supports the concept of an Al-B5 configuration for the holotoxin in which the A subunit is 20 kD and the individual B subunit is 7 kD. The setlB gene has an upstream promoter governing the transcription of both setlB and setlA genes (Fig. 7) . Analysis of the amino acid sequence revealed a peptide structure with a predicted signal sequence. Comparison of the predicted protein 2858 Fasano et al. Cloning of set genes. set orfs were cloned in pBluescript±, and the plasmid so obtained was transformed in DH5a. Immunoblots of the iron-depleted supemnatant obtained from the DH5a(psetl) culture revealed the expression of the 55-kD protein band (Fig. 6 A, lane c; Fig. 6 B, lane c) , which was also detected in S. flexneri 2a strain 2457TA and pF9-1-90 supernatant, but not in the DH5a negative control (Fig. 6 A,  lane a) . DH5a(psetl) supernatant induced an increase in I4, when tested in Ussing chambers (79.18±14.1 MAmp/cm2; n = 6) greater than that seen with S. flexneri 2a wild-type strain 2457TA (38.80±7.6 juAmp/cm2; n = 6) and DH5a(pF9-l-90) (53.63±11.3 /LAmp/cm2; n = 8). All ShETI-containing supernatants tested in Ussing chambers showed a greater increase of Ic as compared with the changes induced by supernatants obtained from the DH5a(pBS) negative control (10.18±8.51Amp/cm2; n = 7; P < 0.01). Material eluted from the nitrocellulose, corresponding to the 55-kD immunoreactive band (Fig. 6 A, lane c) , induced a significant rise in I., when 
Discussion
Much has been written about the molecular pathogenesis of Shigella with respect to the genes and gene products involved in their ability to invade epithelial cells and thereby to cause dysentery (20) (21) (22) (23) (24) . In contrast, surprisingly little is known of the precise mechanisms by which Shigella cause watery diarrhea. It has previously been hypothesized that Shigella produce an enterotoxin. However, except for the cytotoxin/neurotoxin/ enterotoxin elaborated by S. dysenteriae 1 (25) (26) (27) , little convincing proof has been generated to substantiate the contention that these organisms in fact produce enterotoxins. Nevertheless, several observations have strongly predicted the existence of enterotoxins in S. flexneri:
(a) Clinically in humans, S. flexneri infections are usually characterized by a period of watery diarrhea that precedes the onset of scanty dysenteric stools of blood and mucus (7, 28) . Indeed, in mild cases, only watery diarrhea may occur, leading to a clinical picture indistinguishable from enterotoxigenic E. coli infection (29, 30) .
(b) When S. flexneri 2a are fed to monkeys, three clinical syndromes are seen (1) . Some monkeys develop only dysentery, some exhibit only watery diarrhea, and some manifest both diarrhea and dysentery. In vivo perfusion studies by Rout et al. (1) showed that net transport of water into the lumen of the colon occurs in all ill animals. In contrast, only in the jejunum of monkeys with overt watery diarrhea (alone or followed by dysentery) does there occur net secretion of water, sodium, and chloride ions; such net transport does not occur in the jejunum of monkeys manifesting dysentery without watery diarrhea. Net secretion in the jejunum was not accompanied by abnormal histological findings in this anatomic site of the small intestine.
(c) The net secretion of water and electrolytes into the jejunum of monkeys with watery diarrhea requires the passage of S. flexneri 2a through the jejunum (2 intracecal inoculation, whereas no abnormalities of water or electrolyte transport were observed in the jejunum of the ill animals.
Together, these observations strongly suggest that Shigella elaborate enterotoxins that elicit secretion early in the infection as the organisms pass through the jejunum. Our studies validate these earlier physiologic observations, since we now demonstrate that supernatants of S. flexneri 2a contain at least two distinct enterotoxins active both in Ussing chamber experiments (in which significant changes in I,, were recorded) and in isolated rabbit ileal loops (in which significant fluid accumulation was documented). The fluid/gut length ratios recorded in the rabbit ileal loops (average of 0.5 ml/cm) are substantially less than those seen with enterotoxigenic E. coli or EHEC, in which ratios of 1.5-2.0 ml/cm occur. Nevertheless, this still represents definite, albeit mild, net secretion and fluid accumulation.
Plasmid-cured derivatives of strain M4243 showed less enterotoxic activity compared with the wild type in both ileal loops and Ussing chambers. We have recently established that the enhanced enterotoxic activity conferred upon S. flexneri 2a by its virulence plasmid reflects the presence of a plasmid gene encoding a distinct enterotoxin (ShET2 [5] ).
Convalescent sera from volunteers who were fed wild-type S. flexneri 2a were shown to contain antibodies that neutralize the enterotoxic activity of plasmid-minus S. flexneri 2a supernatants in Ussing chambers. Moreover, these convalescent sera contained antibodies that specifically bind to immobilized protein shown to produce enterotoxic activity. At the least, these serologic responses confirm the expression of ShET1 in vivo in the course of human infection, even if they cannot be construed as constituting proof that the toxin actually mediates intestinal secretion. Given the plethora of virulence properties exhibited by virulent Shigella and the complexity of pathogenesis that involves interaction with the host, it will be difficult to ascribe a specific role to ShET1. Nevertheless, we plan to undertake clinical studies in the future that will attempt to assess the actual pathogenic role of ShETI. These include: (a) a randomized, double-blind volunteer study involving oral challenge of subjects with either wild-type S. flexneri 2a or a mutant harboring a deletion in set and (b) an intestinal perfusion study in which intestinal secretion will be measured in volunteers randomly allocated to be exposed to partially purified ShETl (30- 100 kD retentate of plasmid-minus S. flexneri 2a) or to a control preparation (an analogous retentate prepared from an isogenic mutant in which set is inactivated). Results of these planned studies may allow a pathophysiologic role to be attributed to ShETl.
Earlier attempts by other investigators to detect enterotoxic activity in supernatants of S. flexneri yielded negative results with the exception of reports from two groups (31) (32) (33) (34) . In none of these reports is there a resemblance to the findings reported herein for a novel putative S. flexneri 2a enterotoxin for which we suggest the abbreviation ShET1. Specifically, Ketyi et al. (32) (33) (34) reported heat-stable enterotoxin elaborated by S. flexneri 3a and 2a strains that caused dilatation of rabbit ileal loops at 4 h but not at 18-24 h (when the effects that we observed were maximal). O'Brien et al. (31) reported a partially purified toxin prepared from S. flexneri 2a strain M4243 that showed cytotoxic activity against HeLa cells which was partially neutralized by Shiga toxin antiserum. This material elicited positive rabbit ileal loops (it was not stated whether these were read at 4 h or at 18-24 h) and was lethal for mice. The ShETl rabbit ileal loop activity that we observed was clearly separable from any cytotoxic activity elaborated in M4243 supernatants. Moreover, neither of the earlier groups used the conditions of iron limitation that appear to be necessary for expression of ShETl and ShET2. In summary, the few previous reports of enterotoxic activity exhibited by S. flexneri 2a appear to involve entities distinct from ShETl.
Analysis of the sequence of the cloned genes responsible for ShETl enterotoxic activity revealed two distinct, yet contiguous, orfs encoding two proteins of 7 and 20 kD. Similarly, Western blot experiments (Fig. 6) are consistent with one ShETI gene product having a size of -20 kD and another gene product being 7 kD in size. It is intriguing to speculate that ShETI may exhibit the Al-B,, active binding subunit motif commonly encountered among bacterial enterotoxins, including cholera toxin (35) , heat-labile enterotoxin of enterotoxigenic E. coli (36) , and Shiga toxin of S. dysenteriae 1 (37, 38) . By extrapolation, since the ShETl holotoxin has an apparent size of 55 kD, it is tantalizing to speculate that an Al-B5 configuration of one 20-kD subunit (typical of the size of A subunits of 2860 Fasano et al.
GCMGT=GTTCAT GITGAGT other enterotoxins) bonded to five B subunits, each 7 kD in size (typical of B subunits of other enterotoxins), may be responsible. At present this must be regarded purely as speculation. However, important aims of our further research will be to characterize the physical properties of the ShETI holotoxin and to determine the role of the gene product of each of the two orfs. We recognize that in the current study our characterization of the properties of the enterotoxin expressed by S. flexneri 2a after growth in iron-limited medium represents a preliminary finding. More intensive investigations into ShETI and its mode of action await development of preparative purification methods. Studies are underway to characterize further the regulation and biochemistry of this new enterotoxin.
